Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,370 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Deciphering the role of adjuvant therapy in melanoma and its actual benefits.
Fukushima S, Miyashita A, Kimura T, Kuriyama H, Mizuhashi S, Ichigozaki Y, Masuguchi S. Fukushima S, et al. Among authors: kimura t. J Dermatol. 2024 Mar;51(3):335-342. doi: 10.1111/1346-8138.17093. Epub 2024 Jan 11. J Dermatol. 2024. PMID: 38212945 Free PMC article. Review.
Myasthenic crisis and polymyositis induced by one dose of nivolumab.
Kimura T, Fukushima S, Miyashita A, Aoi J, Jinnin M, Kosaka T, Ando Y, Matsukawa M, Inoue H, Kiyotani K, Park JH, Nakamura Y, Ihn H. Kimura T, et al. Cancer Sci. 2016 Jul;107(7):1055-8. doi: 10.1111/cas.12961. Cancer Sci. 2016. PMID: 27420474 Free PMC article.
Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia.
Takamatsu K, Nakane S, Suzuki S, Kosaka T, Fukushima S, Kimura T, Miyashita A, Mukaino A, Yamakawa S, Watanabe K, Jinnin M, Komohara Y, Ihn H, Ando Y. Takamatsu K, et al. Among authors: kimura t. Ann Clin Transl Neurol. 2018 Sep 23;5(11):1421-1427. doi: 10.1002/acn3.654. eCollection 2018 Nov. Ann Clin Transl Neurol. 2018. PMID: 30480036 Free PMC article.
MicroRNAs that predict the effectiveness of anti-PD-1 therapies in patients with advanced melanoma.
Nakahara S, Fukushima S, Okada E, Morinaga J, Kubo Y, Tokuzumi A, Matsumoto S, Tsuruta-Kadohisa M, Kimura T, Kuriyama H, Miyashita A, Kajihara I, Jinnin M, Ihn H. Nakahara S, et al. Among authors: kimura t. J Dermatol Sci. 2020 Jan;97(1):77-79. doi: 10.1016/j.jdermsci.2019.11.010. Epub 2019 Nov 30. J Dermatol Sci. 2020. PMID: 31843231 No abstract available.
Induced pluripotent stem cell-derived myeloid cells expressing OX40 ligand amplify antigen-specific T cells in advanced melanoma.
Kimura T, Fukushima S, Okada E, Kuriyama H, Kanemaru H, Kadohisa-Tsuruta M, Kubo Y, Nakahara S, Tokuzumi A, Kajihara I, Makino K, Miyashita A, Aoi J, Makino T, Tsukamoto H, Nishimura Y, Inozume T, Zhang R, Uemura Y, Senju S, Ihn H. Kimura T, et al. Pigment Cell Melanoma Res. 2020 Sep;33(5):744-755. doi: 10.1111/pcmr.12887. Epub 2020 May 18. Pigment Cell Melanoma Res. 2020. PMID: 32353897
BATF2 expression as a novel marker for invasive phenotype in malignant melanoma.
Tagawa H, Kanemaru H, Kimura T, Kuriyama H, Sawamura S, Kajihara I, Miyashita A, Aoi J, Fukushima S, Ihn H. Tagawa H, et al. Among authors: kimura t. J Dermatol. 2020 Oct;47(10):e372-e373. doi: 10.1111/1346-8138.15495. Epub 2020 Jul 21. J Dermatol. 2020. PMID: 32696470 No abstract available.
10,370 results
You have reached the last available page of results. Please see the User Guide for more information.